Trial Outcomes & Findings for Continuous Glucose Sensor Profiles in Non-Diabetic Subjects (NCT NCT00717977)
NCT ID: NCT00717977
Last Updated: 2016-10-19
Results Overview
Mean glucose value was calculated for every hour of the 24 hours of the day. This measure is the average over all 24 hours.
COMPLETED
PHASE4
74 participants
48-72 hours
2016-10-19
Participant Flow
The study was conducted at 10 adult and pediatric diabetes centers, after approval by their institutional review boards. Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an individual with type 1 diabetes.
Participant milestones
| Measure |
All Non-Diabetic Subjects
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Overall Study
STARTED
|
74
|
|
Overall Study
COMPLETED
|
74
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Continuous Glucose Sensor Profiles in Non-Diabetic Subjects
Baseline characteristics by cohort
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Age, Customized
8-<15 years
|
20 Participants
n=5 Participants
|
|
Age, Customized
15-<25 years
|
17 Participants
n=5 Participants
|
|
Age, Customized
25-<45 years
|
20 Participants
n=5 Participants
|
|
Age, Customized
>=45 years
|
17 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
51 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
23 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic, Caucasian
|
55 Participant
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
13 Participant
n=5 Participants
|
|
Race/Ethnicity, Customized
African American
|
1 Participant
n=5 Participants
|
|
Race/Ethnicity, Customized
Other Race/Ethnicities
|
5 Participant
n=5 Participants
|
|
2-hour post-oral glucose tolerance test (OGTT)
|
96 mg/dL
STANDARD_DEVIATION 22 • n=5 Participants
|
|
Fasting Glucose
|
86 mg/dL
STANDARD_DEVIATION 8 • n=5 Participants
|
|
Hemoglobin A1c
All
|
5.3 Percent
STANDARD_DEVIATION 0.3 • n=5 Participants
|
|
Hemoglobin A1c
8-<15 years
|
5.3 Percent
STANDARD_DEVIATION 0.2 • n=5 Participants
|
|
Hemoglobin A1c
15-<25 years
|
5.2 Percent
STANDARD_DEVIATION 0.2 • n=5 Participants
|
|
Hemoglobin A1c
25-<45 years
|
5.2 Percent
STANDARD_DEVIATION 0.3 • n=5 Participants
|
|
Hemoglobin A1c
>=45 years
|
5.5 Percent
STANDARD_DEVIATION 0.3 • n=5 Participants
|
PRIMARY outcome
Timeframe: 48-72 hoursMean glucose value was calculated for every hour of the 24 hours of the day. This measure is the average over all 24 hours.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Overall Mean Sensor Glucose by Age Group
All
|
98 mg/dL
Standard Deviation 10
|
|
Overall Mean Sensor Glucose by Age Group
8-<15 years
|
103 mg/dL
Standard Deviation 11
|
|
Overall Mean Sensor Glucose by Age Group
15-<25 years
|
97 mg/dL
Standard Deviation 7
|
|
Overall Mean Sensor Glucose by Age Group
25-<45 years
|
96 mg/dL
Standard Deviation 12
|
|
Overall Mean Sensor Glucose by Age Group
>=45 years
|
95 mg/dL
Standard Deviation 7
|
PRIMARY outcome
Timeframe: 48-72 hoursMean glucose value was calculated for every hour of the 24 hours of the day. This measure is the average from 6 a.m. to midnight.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Daytime (6:00 a.m. - Midnight) Mean Sensor Glucose by Age Group
All
|
99 mg/dL
Standard Deviation 10
|
|
Daytime (6:00 a.m. - Midnight) Mean Sensor Glucose by Age Group
8-<15 years
|
103 mg/dL
Standard Deviation 10
|
|
Daytime (6:00 a.m. - Midnight) Mean Sensor Glucose by Age Group
15-<25 years
|
98 mg/dL
Standard Deviation 7
|
|
Daytime (6:00 a.m. - Midnight) Mean Sensor Glucose by Age Group
25-<45 years
|
97 mg/dL
Standard Deviation 12
|
|
Daytime (6:00 a.m. - Midnight) Mean Sensor Glucose by Age Group
>=45 years
|
97 mg/dL
Standard Deviation 6
|
PRIMARY outcome
Timeframe: 48-72 hoursMean glucose value was calculated for every hour of the 24 hours of the day. This measure is the average from midnight to 6 a.m.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Nighttime (Midnight - 6:00 a.m.) Mean Sensor Glucose by Age Group
All
|
95 mg/dL
Standard Deviation 13
|
|
Nighttime (Midnight - 6:00 a.m.) Mean Sensor Glucose by Age Group
8-<15 years
|
101 mg/dL
Standard Deviation 15
|
|
Nighttime (Midnight - 6:00 a.m.) Mean Sensor Glucose by Age Group
15-<25 years
|
97 mg/dL
Standard Deviation 11
|
|
Nighttime (Midnight - 6:00 a.m.) Mean Sensor Glucose by Age Group
25-<45 years
|
91 mg/dL
Standard Deviation 12
|
|
Nighttime (Midnight - 6:00 a.m.) Mean Sensor Glucose by Age Group
>=45 years
|
89 mg/dL
Standard Deviation 11
|
PRIMARY outcome
Timeframe: 48-72 hoursThe calculation of peak and nadir glucose was restricted to days with \>=12 hours and nights with \>=4 hours of sensor glucose data.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Peak Daytime Sensor Glucose Value by Age Group
All
|
131 mg/dL
Interval 121.0 to 140.0
|
|
Peak Daytime Sensor Glucose Value by Age Group
8-<15 years
|
134 mg/dL
Interval 128.0 to 145.0
|
|
Peak Daytime Sensor Glucose Value by Age Group
15-<25 years
|
135 mg/dL
Interval 119.0 to 144.0
|
|
Peak Daytime Sensor Glucose Value by Age Group
25-<45 years
|
125 mg/dL
Interval 118.0 to 134.0
|
|
Peak Daytime Sensor Glucose Value by Age Group
>=45 years
|
128 mg/dL
Interval 122.0 to 134.0
|
PRIMARY outcome
Timeframe: 48-72 hoursThe calculation of peak and nadir glucose was restricted to days with \>=12 hours and nights with \>=4 hours of sensor glucose data.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Peak Nightime Sensor Glucose Value by Age Group
All
|
109 mg/dL
Interval 99.0 to 118.0
|
|
Peak Nightime Sensor Glucose Value by Age Group
8-<15 years
|
111 mg/dL
Interval 108.0 to 120.0
|
|
Peak Nightime Sensor Glucose Value by Age Group
15-<25 years
|
111 mg/dL
Interval 106.0 to 118.0
|
|
Peak Nightime Sensor Glucose Value by Age Group
25-<45 years
|
104 mg/dL
Interval 95.0 to 111.0
|
|
Peak Nightime Sensor Glucose Value by Age Group
>=45 years
|
103 mg/dL
Interval 97.0 to 113.0
|
PRIMARY outcome
Timeframe: 48-72 hoursThe calculation of peak and nadir glucose was restricted to days with \>=12 hours and nights with \>=4 hours of sensor glucose data. The daytime nadir reflects the lowest point on the sensor glucose curve registered among daytime values.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Daytime Nadir Sensor Glucose Value by Age Group
All
|
73 mg/dL
Interval 68.0 to 82.0
|
|
Daytime Nadir Sensor Glucose Value by Age Group
8-<15 Years
|
74 mg/dL
Interval 68.0 to 86.0
|
|
Daytime Nadir Sensor Glucose Value by Age Group
15-<25 Years
|
71 mg/dL
Interval 67.0 to 77.0
|
|
Daytime Nadir Sensor Glucose Value by Age Group
25-<45 Years
|
75 mg/dL
Interval 67.0 to 82.0
|
|
Daytime Nadir Sensor Glucose Value by Age Group
>=45 Years
|
79 mg/dL
Interval 68.0 to 84.0
|
PRIMARY outcome
Timeframe: 48-72 hoursThe calculation of peak and nadir glucose was restricted to days with \>=12 hours and nights with \>=4 hours of sensor glucose data. The nighttime nadir reflects the lowest point on the sensor glucose curve registered among nighttime values.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Nighttime Nadir Sensor Glucose Value by Age Group
All
|
80 mg/dL
Interval 73.0 to 89.0
|
|
Nighttime Nadir Sensor Glucose Value by Age Group
5-<15 Years
|
84 mg/dL
Interval 78.0 to 91.0
|
|
Nighttime Nadir Sensor Glucose Value by Age Group
15-<25 Years
|
80 mg/dL
Interval 76.0 to 93.0
|
|
Nighttime Nadir Sensor Glucose Value by Age Group
25-<45 Years
|
77 mg/dL
Interval 67.0 to 88.0
|
|
Nighttime Nadir Sensor Glucose Value by Age Group
>=45 Years
|
78 mg/dL
Interval 78.0 to 86.0
|
PRIMARY outcome
Timeframe: 48-72 hoursThe Percentage Sensor Glucose Levels between 71-120 mg/dL was calculated for each subject. The median and quartiles over all subjects were reported here.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Percentage of Sensor Glucose Levels Between 71-120 mg/dL by Age Group
All
|
91.0 Percent
Interval 79.0 to 94.0
|
|
Percentage of Sensor Glucose Levels Between 71-120 mg/dL by Age Group
8-<15 Years
|
85.1 Percent
Interval 79.0 to 92.0
|
|
Percentage of Sensor Glucose Levels Between 71-120 mg/dL by Age Group
15-<25 Years
|
87.9 Percent
Interval 76.0 to 96.0
|
|
Percentage of Sensor Glucose Levels Between 71-120 mg/dL by Age Group
25-<45 Years
|
91.4 Percent
Interval 78.0 to 94.0
|
|
Percentage of Sensor Glucose Levels Between 71-120 mg/dL by Age Group
>=45 Years
|
93.7 Percent
Interval 88.0 to 95.0
|
PRIMARY outcome
Timeframe: 48-72 hoursOutcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Percentage of Sensor Glucose Levels 71-120 mg/dL by Time of Day
Daytime (6am-midnight)
|
90.4 Percent
Interval 80.0 to 95.0
|
|
Percentage of Sensor Glucose Levels 71-120 mg/dL by Time of Day
Nightime (midnight-6am)
|
90.3 Percent
Interval 76.0 to 98.0
|
PRIMARY outcome
Timeframe: 48-72 hoursOutcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Distribution of Sensor Glucose Levels <=70 mg/dL by Age Group
All
|
1.7 Percent
Interval 0.0 to 7.2
|
|
Distribution of Sensor Glucose Levels <=70 mg/dL by Age Group
8-<15 Years
|
1.8 Percent
Interval 0.0 to 4.3
|
|
Distribution of Sensor Glucose Levels <=70 mg/dL by Age Group
15-<25 Years
|
0.6 Percent
Interval 0.0 to 8.1
|
|
Distribution of Sensor Glucose Levels <=70 mg/dL by Age Group
25-<45 Years
|
2.9 Percent
Interval 0.0 to 8.1
|
|
Distribution of Sensor Glucose Levels <=70 mg/dL by Age Group
>=45 Years
|
1.6 Percent
Interval 0.0 to 6.3
|
PRIMARY outcome
Timeframe: 48-72 hoursOutcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Percentage of Sensor Glucose Levels <=70 mg/dl by Time of Day
Daytime (6am-midnight)
|
1.1 Percent
Interval 0.0 to 5.1
|
|
Percentage of Sensor Glucose Levels <=70 mg/dl by Time of Day
Nighttime (midnight-6am)
|
2.2 Percent
Interval 0.0 to 12.0
|
PRIMARY outcome
Timeframe: 48-72 hoursOutcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Percentage of Sensor Glucose Levels <=60 mg/dL by Age Group
All
|
0.2 Percent
Interval 0.0 to 1.7
|
|
Percentage of Sensor Glucose Levels <=60 mg/dL by Age Group
8-<15 Years
|
0.2 Percent
Interval 0.0 to 1.8
|
|
Percentage of Sensor Glucose Levels <=60 mg/dL by Age Group
15-<25 Years
|
0.0 Percent
Interval 0.0 to 3.1
|
|
Percentage of Sensor Glucose Levels <=60 mg/dL by Age Group
25-<45 Years
|
0.2 Percent
Interval 0.0 to 1.3
|
|
Percentage of Sensor Glucose Levels <=60 mg/dL by Age Group
>=45 Years
|
0.1 Percent
Interval 0.0 to 1.3
|
PRIMARY outcome
Timeframe: 48-72 hoursThe Percentage of Sensor Glucose Levels \<=60 mg/dl was calculated for each subject separately for the daytime and nighttime period. The median and quartiles over all subjects were reported. Here the data is different with data analyzed by age group, which is a subgroup analysis on 'percentage of sensor glucose levels \<=60mg/dL' for all 24 hours.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Percentage of Sensor Glucose Levels <=60 mg/dl by Time of Day
Daytime (6am-midnight)
|
0.0 Percent
Interval 0.0 to 1.2
|
|
Percentage of Sensor Glucose Levels <=60 mg/dl by Time of Day
Nighttime (midnight-6am)
|
0.0 Percent
Interval 0.0 to 1.3
|
PRIMARY outcome
Timeframe: 48-72 hoursOutcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Percentage of Sensor Glucose Levels >120 mg/dL by Age Group
All
|
5.6 Percent
Interval 2.2 to 9.3
|
|
Percentage of Sensor Glucose Levels >120 mg/dL by Age Group
8-<15 Years
|
8.2 Percent
Interval 5.6 to 16.0
|
|
Percentage of Sensor Glucose Levels >120 mg/dL by Age Group
15-<25 Years
|
8.3 Percent
Interval 3.1 to 13.0
|
|
Percentage of Sensor Glucose Levels >120 mg/dL by Age Group
25-<45 Years
|
4.2 Percent
Interval 1.8 to 7.1
|
|
Percentage of Sensor Glucose Levels >120 mg/dL by Age Group
>=45 Years
|
4.4 Percent
Interval 1.2 to 5.8
|
PRIMARY outcome
Timeframe: 48-72 hoursOutcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Percentage of Sensor Glucose Levels >120 mg/dl by Time of Day
Daytime (6am-midnight)
|
5.9 Percent
Interval 2.4 to 11.0
|
|
Percentage of Sensor Glucose Levels >120 mg/dl by Time of Day
Nighttime (midnight-6am)
|
1.1 Percent
Interval 0.0 to 11.0
|
PRIMARY outcome
Timeframe: 48-72 hoursOutcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Percentage of Sensor Glucose Levels >140 mg/dL by Age Group
All
|
0.4 Percent
Interval 0.0 to 1.7
|
|
Percentage of Sensor Glucose Levels >140 mg/dL by Age Group
5-<15 Years
|
1.3 Percent
Interval 0.3 to 3.7
|
|
Percentage of Sensor Glucose Levels >140 mg/dL by Age Group
15-<25 Years
|
0.3 Percent
Interval 0.0 to 1.5
|
|
Percentage of Sensor Glucose Levels >140 mg/dL by Age Group
25-<45 Years
|
0.3 Percent
Interval 0.0 to 1.9
|
|
Percentage of Sensor Glucose Levels >140 mg/dL by Age Group
>=45 Years
|
0.0 Percent
Interval 0.0 to 1.0
|
PRIMARY outcome
Timeframe: 48-72 hoursThe Percentage of Sensor Glucose Levels \>140 mg/dl was calculated for each subject separately for the daytime and nighttime period. The median and quartiles over all subjects were reported. Here the data is different with data analyzed by age group, which is a subgroup analysis on 'percentage of sensor glucose levels \>140 mg/dl' for all 24 hours.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Percentage of Sensor Glucose Levels >140 mg/dl by Time of Day
Daytime (6am-midnight)
|
0.5 Percent
Interval 0.0 to 2.3
|
|
Percentage of Sensor Glucose Levels >140 mg/dl by Time of Day
Nighttime (midnight-6am)
|
0.0 Percent
Interval 0.0 to 0.0
|
PRIMARY outcome
Timeframe: 48-72 hoursHere, 'Standard Deviation' is a measure of glucose variability. This measure was calculated by taking the SD of all glucose values for each subject. Each subject has a SD value. The median and quartiles of this measure over all subjects were reported.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Glucose Variability Measure- Standard Deviation by Age Group
All
|
13.7 mg/dL
Interval 11.4 to 18.0
|
|
Glucose Variability Measure- Standard Deviation by Age Group
8-<15 Years
|
16.4 mg/dL
Interval 13.2 to 19.1
|
|
Glucose Variability Measure- Standard Deviation by Age Group
15-<25 Years
|
13.7 mg/dL
Interval 11.1 to 19.9
|
|
Glucose Variability Measure- Standard Deviation by Age Group
25-<45 Years
|
12.6 mg/dL
Interval 12.1 to 16.5
|
|
Glucose Variability Measure- Standard Deviation by Age Group
>=45 Years
|
12.4 mg/dL
Interval 10.0 to 15.9
|
PRIMARY outcome
Timeframe: 48-72 hoursHere, 'Standard Deviation' is a measure of glucose variability. This measure was calculated by taking the SD of all glucose values for each subject. Each subject has a SD value. The median and quartiles of this measure over all subjects were reported.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Glucose Variability Measure- Standard Deviation by Time of Day
Daytime (6am-midnight)
|
13.5 mg/dL
Interval 11.3 to 17.8
|
|
Glucose Variability Measure- Standard Deviation by Time of Day
Nighttime (midnight-6am)
|
10.9 mg/dL
Interval 8.2 to 16.8
|
PRIMARY outcome
Timeframe: 48-72 hoursOutcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Glucose Variability Measure- Absolute Rate of Change by Age Group
All
|
0.34 mg/dL/min
Interval 0.3 to 0.41
|
|
Glucose Variability Measure- Absolute Rate of Change by Age Group
8-<15 Years
|
0.36 mg/dL/min
Interval 0.36 to 0.46
|
|
Glucose Variability Measure- Absolute Rate of Change by Age Group
15-<25 Years
|
0.34 mg/dL/min
Interval 0.3 to 0.39
|
|
Glucose Variability Measure- Absolute Rate of Change by Age Group
25-<45 Years
|
0.32 mg/dL/min
Interval 0.28 to 0.37
|
|
Glucose Variability Measure- Absolute Rate of Change by Age Group
>=45 Years
|
0.33 mg/dL/min
Interval 0.24 to 0.41
|
PRIMARY outcome
Timeframe: 48-72 hoursOutcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Glucose Variability Measure- Absolute Rate of Change by Time of Day
Daytime (6am-midnight)
|
0.37 mg/dL/min
Interval 0.32 to 0.43
|
|
Glucose Variability Measure- Absolute Rate of Change by Time of Day
Nighttime (midnight-6am)
|
0.26 mg/dL/min
Interval 0.18 to 0.35
|
PRIMARY outcome
Timeframe: 48-72 hoursThe Coefficient of Variation is calculated by dividing the standard deviation by the mean glucose. Each subject received a SD value. The median and quartiles of this measure over all subjects were reported.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Glucose Variability Measure- Coefficient of Variation by Age Group
All
|
14 Percent
Interval 12.0 to 19.0
|
|
Glucose Variability Measure- Coefficient of Variation by Age Group
8-<15 Years
|
16 Percent
Interval 13.0 to 19.0
|
|
Glucose Variability Measure- Coefficient of Variation by Age Group
15-<25 Years
|
14 Percent
Interval 12.0 to 21.0
|
|
Glucose Variability Measure- Coefficient of Variation by Age Group
25-<45 Years
|
14 Percent
Interval 13.0 to 17.0
|
|
Glucose Variability Measure- Coefficient of Variation by Age Group
>=45 Years
|
13 Percent
Interval 10.0 to 16.0
|
PRIMARY outcome
Timeframe: 48-72 hoursThe Coefficient of Variation is calculated by dividing the standard deviation by the mean glucose. Each subject received a SD value. The median and quartiles of this measure over all subjects were reported.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Glucose Variability Measure- Coefficient of Variation by Time of Day
Daytime (6am-midnight)
|
14 Percent
Interval 12.0 to 18.0
|
|
Glucose Variability Measure- Coefficient of Variation by Time of Day
Nighttime (midnight-6am)
|
12 Percent
Interval 9.0 to 19.0
|
PRIMARY outcome
Timeframe: 48-72 hoursThe Mean Amplitude of Glycemic Excursions also known as MAGE depicts the upward and downward acute glucose fluctuations seen in the sensor data.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Glucose Variability Measure: Mean Amplitude of Glycemic Excursions by Age Group
All
|
27.7 mg/dL
Interval 23.1 to 33.1
|
|
Glucose Variability Measure: Mean Amplitude of Glycemic Excursions by Age Group
8-<15 Years
|
28.1 mg/dL
Interval 23.9 to 33.2
|
|
Glucose Variability Measure: Mean Amplitude of Glycemic Excursions by Age Group
15-<25 Years
|
28.3 mg/dL
Interval 25.1 to 33.1
|
|
Glucose Variability Measure: Mean Amplitude of Glycemic Excursions by Age Group
25-<45 Years
|
25.6 mg/dL
Interval 22.8 to 31.4
|
|
Glucose Variability Measure: Mean Amplitude of Glycemic Excursions by Age Group
>=45 Years
|
26.9 mg/dL
Interval 21.4 to 34.1
|
PRIMARY outcome
Timeframe: 48-72 hoursThe Mean Amplitude of Glycemic Excursions also known as MAGE depicts the upward and downward acute glucose fluctuations seen in the sensor data.
Outcome measures
| Measure |
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
|
|---|---|
|
Glucose Variability Measure: Amplitude of Glycemic Excursions by Time of Day
Daytime (6am-midnight)
|
28.0 mg/dL
Interval 23.8 to 31.9
|
|
Glucose Variability Measure: Amplitude of Glycemic Excursions by Time of Day
Nighttime (midnight-6am)
|
15.8 mg/dL
Interval 12.3 to 20.3
|
Adverse Events
All Non-Diabetic Subjects
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Roy W. Beck, M.D., Ph.D.
Jaeb Center for Health Research
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60